Not only is Valeant Pharmaceuticals (NYSE:VRX) reportedly prepping a bid for Salix Pharmaceuticals (NASDAQ:SLXP), but Shire (NASDAQ:SHPG) is now rumored to be preparing an offer. Shire has taken initial steps towards a bid and is evaluating how to secure financing, sources told Reuters. Yesterday, Valeant Pharmaceuticals (VRX) was reported to be arranging financing for a takeout of Salix at a likely price of more than $150 per share. Including net debt, Salix is valued at almost $11B. Previously: Valeant close to a bid for Salix (Feb. 12 2015) SLXP +1.2% premarket http://seekingalpha.com/news/2297376-shire-now-on-the-hunt-for-salix#
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.